Cargando…

Is there any difference between oral preemptive pregabalin vs. placebo administration on response to EBUS-TBNA under sedation?

BACKGROUND/AIM: The aim of this study is to evaluate the effects of preemptive oral pregabalin on hemodynamic response, anxiety, sedation, and recovery in patients who underwent endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA) under sedation with intravenous ketamine-prop...

Descripción completa

Detalles Bibliográficos
Autores principales: AYDEMİR, Semih, ALAGÖZ, Ali, ULUS, Fatma, TUNÇ, Mehtap, SAZAK, Hilal, DEMİRCİ, Nilgün Yılmaz
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Scientific and Technological Research Council of Turkey 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7991850/
https://www.ncbi.nlm.nih.gov/pubmed/33172225
http://dx.doi.org/10.3906/sag-2005-305
_version_ 1783669255507542016
author AYDEMİR, Semih
ALAGÖZ, Ali
ULUS, Fatma
TUNÇ, Mehtap
SAZAK, Hilal
DEMİRCİ, Nilgün Yılmaz
author_facet AYDEMİR, Semih
ALAGÖZ, Ali
ULUS, Fatma
TUNÇ, Mehtap
SAZAK, Hilal
DEMİRCİ, Nilgün Yılmaz
author_sort AYDEMİR, Semih
collection PubMed
description BACKGROUND/AIM: The aim of this study is to evaluate the effects of preemptive oral pregabalin on hemodynamic response, anxiety, sedation, and recovery in patients who underwent endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA) under sedation with intravenous ketamine-propofol combination. MATERIALS AND METHODS: Sixty patients were included in this study, and patients were randomly divided into two equal groups to receive the placebo (Group 1) versus pregabalin 150 mg (Group 2) one hour prior to EBUS- TBNA procedure. Patients received 0.25 mg kg(-1) ketamine and 0.25 mg kg(-1) propofol mixture (ketofol) for sedation. Timing of the parameters was defined as follows; T0: in hospital ward before pregabalin or placebo administration, T1: premedication, T2: in operating room, T3: before the procedure, T4: initiation, T5: 3 min after induction, T6: 6 min after induction, T7: 9 min after induction, and T8: 12 min after induction. Hemodynamic parameters, severity of coughing, sedation and anxiety scores, and complications were recorded. The level of satisfaction of the bronchoscopist and the patients were evaluated at the end of the procedure. RESULTS: The heart rate and mean arterial pressure were significantly higher in Group 1 (P = 0.008, P = 0.04). Total doses of anesthetics, recovery time, and desaturation rate were significantly higher in Group 1 (P = 0.014, P = 0.001, P = 0.045). In Group 2, SpO(2) level was significantly higher at various time periods (T1; P = 0.025, T4; P =0.043, T6; P = 0.001, T7; P = 0.003, T8; P < 0.001). The severity of coughing was found significantly lower in Group 2 (T4; P = 0.011, T5; P = 0.01, T6; P = 0.02, T7; P = 0.03, T8; P < 0.01). Anxiety scores were significantly lower in Group 2 (P < 0.001). CONCLUSION: Preemptive oral pregabalin, in addition to sedation with ketamine-propofol combination, was effective in providing limited hemodynamic response, restricted coughing reflex, and lower anxiety during EBUS-TBNA. Besides, with pregabalin usage, decreased anesthetics consumption, lower complication rate, and shorter recovery time might have contributed to safety of the procedure and comfort of the bronchoscopist.
format Online
Article
Text
id pubmed-7991850
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher The Scientific and Technological Research Council of Turkey
record_format MEDLINE/PubMed
spelling pubmed-79918502021-03-30 Is there any difference between oral preemptive pregabalin vs. placebo administration on response to EBUS-TBNA under sedation? AYDEMİR, Semih ALAGÖZ, Ali ULUS, Fatma TUNÇ, Mehtap SAZAK, Hilal DEMİRCİ, Nilgün Yılmaz Turk J Med Sci Article BACKGROUND/AIM: The aim of this study is to evaluate the effects of preemptive oral pregabalin on hemodynamic response, anxiety, sedation, and recovery in patients who underwent endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA) under sedation with intravenous ketamine-propofol combination. MATERIALS AND METHODS: Sixty patients were included in this study, and patients were randomly divided into two equal groups to receive the placebo (Group 1) versus pregabalin 150 mg (Group 2) one hour prior to EBUS- TBNA procedure. Patients received 0.25 mg kg(-1) ketamine and 0.25 mg kg(-1) propofol mixture (ketofol) for sedation. Timing of the parameters was defined as follows; T0: in hospital ward before pregabalin or placebo administration, T1: premedication, T2: in operating room, T3: before the procedure, T4: initiation, T5: 3 min after induction, T6: 6 min after induction, T7: 9 min after induction, and T8: 12 min after induction. Hemodynamic parameters, severity of coughing, sedation and anxiety scores, and complications were recorded. The level of satisfaction of the bronchoscopist and the patients were evaluated at the end of the procedure. RESULTS: The heart rate and mean arterial pressure were significantly higher in Group 1 (P = 0.008, P = 0.04). Total doses of anesthetics, recovery time, and desaturation rate were significantly higher in Group 1 (P = 0.014, P = 0.001, P = 0.045). In Group 2, SpO(2) level was significantly higher at various time periods (T1; P = 0.025, T4; P =0.043, T6; P = 0.001, T7; P = 0.003, T8; P < 0.001). The severity of coughing was found significantly lower in Group 2 (T4; P = 0.011, T5; P = 0.01, T6; P = 0.02, T7; P = 0.03, T8; P < 0.01). Anxiety scores were significantly lower in Group 2 (P < 0.001). CONCLUSION: Preemptive oral pregabalin, in addition to sedation with ketamine-propofol combination, was effective in providing limited hemodynamic response, restricted coughing reflex, and lower anxiety during EBUS-TBNA. Besides, with pregabalin usage, decreased anesthetics consumption, lower complication rate, and shorter recovery time might have contributed to safety of the procedure and comfort of the bronchoscopist. The Scientific and Technological Research Council of Turkey 2021-02-26 /pmc/articles/PMC7991850/ /pubmed/33172225 http://dx.doi.org/10.3906/sag-2005-305 Text en Copyright © 2021 The Author(s) This article is distributed under the terms of the Creative Commons Attribution License ( http://creativecommons.org/licenses/by/4.0/ ), which permits unrestricted use and redistribution provided that the original author and source are credited.
spellingShingle Article
AYDEMİR, Semih
ALAGÖZ, Ali
ULUS, Fatma
TUNÇ, Mehtap
SAZAK, Hilal
DEMİRCİ, Nilgün Yılmaz
Is there any difference between oral preemptive pregabalin vs. placebo administration on response to EBUS-TBNA under sedation?
title Is there any difference between oral preemptive pregabalin vs. placebo administration on response to EBUS-TBNA under sedation?
title_full Is there any difference between oral preemptive pregabalin vs. placebo administration on response to EBUS-TBNA under sedation?
title_fullStr Is there any difference between oral preemptive pregabalin vs. placebo administration on response to EBUS-TBNA under sedation?
title_full_unstemmed Is there any difference between oral preemptive pregabalin vs. placebo administration on response to EBUS-TBNA under sedation?
title_short Is there any difference between oral preemptive pregabalin vs. placebo administration on response to EBUS-TBNA under sedation?
title_sort is there any difference between oral preemptive pregabalin vs. placebo administration on response to ebus-tbna under sedation?
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7991850/
https://www.ncbi.nlm.nih.gov/pubmed/33172225
http://dx.doi.org/10.3906/sag-2005-305
work_keys_str_mv AT aydemirsemih isthereanydifferencebetweenoralpreemptivepregabalinvsplaceboadministrationonresponsetoebustbnaundersedation
AT alagozali isthereanydifferencebetweenoralpreemptivepregabalinvsplaceboadministrationonresponsetoebustbnaundersedation
AT ulusfatma isthereanydifferencebetweenoralpreemptivepregabalinvsplaceboadministrationonresponsetoebustbnaundersedation
AT tuncmehtap isthereanydifferencebetweenoralpreemptivepregabalinvsplaceboadministrationonresponsetoebustbnaundersedation
AT sazakhilal isthereanydifferencebetweenoralpreemptivepregabalinvsplaceboadministrationonresponsetoebustbnaundersedation
AT demircinilgunyılmaz isthereanydifferencebetweenoralpreemptivepregabalinvsplaceboadministrationonresponsetoebustbnaundersedation